MedTrace Logo

Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency

NCT02293759 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-03-29

No results posted yet for this study

Summary

Patients presented for BPH surgery at our out patient clinic will be assessed for abnormal bleeding profile.

Patients with bleeding tendency will be offered either HoLEP or Greenlight laser PVP based on prostate size cut off point of 80ml Larger prostates will be treated with HoLEP Smaller prostates will be treated with greenlight PVP

Conditions

  • Benign Prostatic Hyperplasia

Interventions

PROCEDURE

HoLEP

Holmium laser enucleation of the prsotate

PROCEDURE

Greenlight laser PVP

Greenlight laser (532nm) Photoslective vaporization of the prostate

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Ahmed m Elshal, MD · Mansoura University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-08-31
Completion
2016-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02293759 on ClinicalTrials.gov